Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.
Neurology. 2015.
PMID: 25681448
Free PMC article.
Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators.
Fox RJ, et al.
N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328.
N Engl J Med. 2012.
PMID: 22992072
Free article.
Clinical Trial.
Item in Clipboard
Initial experience with ropinirole PR (prolonged release).
Jost WH, Buhmann C, Fuchs G, Greulich W, Hummel S, Korchounov A, Müngersdorf M, Schwarz M, Spiegel-Meixensberger M.
Jost WH, et al. Among authors: spiegel meixensberger m.
J Neurol. 2008 Sep;255 Suppl 5:60-3. doi: 10.1007/s00415-008-5008-z.
J Neurol. 2008.
PMID: 18787884
Review.
Item in Clipboard
Cite
Cite